Escape is a more common mechanism than avidity reduction for evasion of CD8+ T cell responses in primary human immunodeficiency virus type 1 infection

Retrovirology

Volumn 8, Issue , 2011, Pages

  Turnbull, Emma L ^a   Baalwa, Joshua ^b   Conrod, Karen E ^a   Wang, Shuyi ^b   Wei, Xiping ^b   Wong, MaiLee ^a   Turner, Joanna ^c   Pellegrino, Pierre ^c   Williams, Ian ^c   Shaw, George M ^b   Borrow, Persephone ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b University of Alabama at Birmingham   (United States)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN; NEF PROTEIN; POL PROTEIN; EPITOPE; VIRUS PROTEIN;

ARTICLE; BINDING AFFINITY; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSPOT ASSAY; EPITOPE MAPPING; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNE EVASION; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; SEROCONVERSION; SYMPTOMATOLOGY; T LYMPHOCYTE; VIRUS LOAD; VIRUS MUTATION; VIRUS REPLICATION; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; MISSENSE MUTATION; VIROLOGY;

HUMAN IMMUNODEFICIENCY VIRUS 1;

CD8-POSITIVE T-LYMPHOCYTES; EPITOPES, T-LYMPHOCYTE; HIV INFECTIONS; HIV-1; HUMANS; IMMUNE EVASION; MUTATION, MISSENSE; VIRAL PROTEINS;

EID: 79957797404     PISSN: None     EISSN: 17424690     Source Type: Journal    
DOI: 10.1186/1742-4690-8-41     Document Type: Article

References (41)

1. Borrow P, Lewicki H, Hahn BH, Shaw GM, Oldstone MB. Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J Virol 1994, 68:6103-6110. 237022, 8057491.
2. Koup RA, Safrit JT, Cao Y, Andrews CA, McLeod G, Borkowsky W, Farthing C, Ho DD. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J Virol 1994, 68:4650-4655. 236393, 8207839.
3. Turnbull EL, Wong M, Wang S, Wei X, Jones NA, Conrod KE, Aldam D, Turner J, Pellegrino P, Keele BF, et al. Kinetics of expansion of epitope-specific T cell responses during primary HIV-1 infection. J Immunol 2009, 182:7131-7145. 10.4049/jimmunol.0803658, 19454710.
4. Borrow P, Lewicki H, Wei X, Horwitz MS, Peffer N, Meyers H, Nelson JA, Gairin JE, Hahn BH, Oldstone MBA, Shaw GM. Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus. Nature Med 1997, 3:205-211. 10.1038/nm0297-205, 9018240.
5. Schmitz JE, Kuroda MJ, Santra S, Sassaville VG, Simon MA, Lifton MA, Racz P, Tenner-Racz K, Dalesandro M, Scallon BJ, et al. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. Science 1999, 283:857-860. 10.1126/science.283.5403.857, 9933172.
6. Goonetilleke N, Liu MK, Salazar-Gonzalez JF, Ferrari G, Giorgi E, Ganusov VV, Keele BF, Learn GH, Turnbull EL, Salazar MG, et al. The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection. J Exp Med 2009, 206:1253-1272. 10.1084/jem.20090365, 2715063, 19487423.
7. Price DA, Goulder PJR, Klenerman P, Sewell AK, Easterbrook PJ, Troop M, Bangham CRM, Phillips RE. Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection. Proc Natl Acad Sci USA 1997, 94:1890-1895. 10.1073/pnas.94.5.1890, 20013, 9050875.
8. Pantaleo G, Soudeyns H, Demarest JF, Vaccarezza M, Graziosi C, Paolucci S, Dauchier M, Cohen OJ, Denis F, Biddison WE, et al. Evidence for rapid disappearance of initially expanded HIV-specific CD8+ T cell clones during primary HIV infection. Proc Natl Acad Sci USA 1997, 94:9848-9853. 10.1073/pnas.94.18.9848, 23280, 9275214.
9. Lichterfeld M, Yu XG, Mui SK, Williams KL, Trocha A, Brockman MA, Allgaier RL, Waring MT, Koibuchi T, Johnston MN, et al. Selective depletion of high-avidity human immunodeficiency virus type 1 (HIV-1)-specific CD8+ T cells after early HIV-1 infection. J Virol 2007, 81:4199-4214. 10.1128/JVI.01388-06, 1866095, 17287271.
10. Appay V, Nixon DF, Donahoe SM, Gillespie GM, Dong T, King A, Ogg GS, Spiegel HM, Conlon C, Spina CA, et al. HIV-specific CD8(+) T cells produce antiviral cytokines but are impaired in cytolytic function. J Exp Med 2000, 192:63-75. 10.1084/jem.192.1.63, 1887711, 10880527.
11. Champagne P, Ogg GS, King AS, Knabenhans C, Ellefsen K, Nobile M, Appay V, Rizzardi GP, Fleury S, Lipp M, et al. Skewed maturation of memory HIV-specific CD8 T lymphocytes. Nature 2001, 410:106-111. 10.1038/35065118, 11242051.
12. Migueles SA, Laborico AC, Shupert WL, Sabbaghian MS, Rabin R, Hallahan CW, van Baarle D, Kostense S, Miedema F, McLaughlin M, et al. HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in non-progressors. Nat Immunol 2002, 3:1061-1068. 10.1038/ni845, 12368910.
13. Betts MR, Nason MC, West SM, De Rosa SC, Migueles SA, Abraham J, Lederman MM, Benito JM, Goepfert PA, Connors M, et al. HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells. Blood 2006, 107:4781-4789. 10.1182/blood-2005-12-4818, 1895811, 16467198.
14. Streeck H, Brumme ZL, Anastario M, Cohen KW, Jolin JS, Meier A, Brumme CJ, Rosenberg ES, Alter G, Allen TM, et al. Antigen load and viral sequence diversification determine the functional profile of HIV-1-specific CD8+ T cells. PLoS Med 2008, 5:e100. 10.1371/journal.pmed.0050100, 2365971, 18462013.
15. Moore CB, John M, James IR, Christiansen FT, Witt CS, Mallal SA. Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level. Science 2002, 296:1439-1443. 10.1126/science.1069660, 12029127.
16. Kawashima Y, Pfafferott K, Frater J, Matthews P, Payne R, Addo M, Gatanaga H, Fujiwara M, Hachiya A, Koizumi H, et al. Adaptation of HIV-1 to human leukocyte antigen class I. Nature 2009, 458:641-645. 10.1038/nature07746, 19242411.
17. Jones NA, Wei X, Flower DR, Wong M, Michor F, Saag MS, Hahn BH, Nowak MA, Shaw GM, Borrow P. Determinants of HIV-1 escape from the primary CD8+ cytotoxic T lymphocyte response. J Exp Med 2004, 200:1243-1256. 10.1084/jem.20040511, 2211924, 15545352.
18. Goulder PJR, Phillips RE, Colbert RA, McAdam S, Ogg G, Nowak MA, Giangrande P, Luzzi G, Morgan B, Edwards A, et al. Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS. Nature Med 1997, 3:212-217. 10.1038/nm0297-212, 9018241.
19. Feeney ME, Tang Y, Roosevelt KA, Leslie AJ, McIntosh K, Karthas N, Walker BD, Goulder PJ. Immune escape precedes breakthrough human immunodeficiency virus type 1 viremia and broadening of the cytotoxic T-lymphocyte response in an HLA-B27-positive long-term-nonprogressing child. J Virol 2004, 78:8927-8930. 10.1128/JVI.78.16.8927-8930.2004, 479057, 15280502.
20. Gallimore A, Dumrese T, Hengartner H, Zinkernagel RM, Rammensee HG. Protective immunity does not correlate with the hierarchy of virus-specific cytotoxic T cell responses to naturally processed peptides. J Exp Med 1998, 187:1647-1657. 10.1084/jem.187.10.1647, 2212291, 9584143.
21. Sedlik C, Dadaglio G, Saron MF, Deriaud E, Rojas M, Casal SI, Leclerc C. In vivo induction of a high-affinity, high frequency cytotoxic T lymphocyte response is assosiated with anti-viral protective immunity. J Virol 2000, 74(13):5769-5775. 10.1128/JVI.74.13.5769-5775.2000, 112070, 10846055.
22. Zeh HJ, Perry-Lalley D, Dudley ME, Rosenberg SA, Yang JC. High avidity CTLs for two self-antigens demonstrate superior in vitro and in vivo antitumor efficacy. J Immunol 1999, 162:989-994.
23. Derby M, Alexander-Miller M, Tse R, Berzofsky J. High-avidity CTL exploit two complementary mechanisms to provide better protection against viral infection than low-avidity CTL. J Immunol 2001, 166:1690-1697.
24. Bennett MS, Ng HL, Dagarag M, Ali A, Yang OO. Epitope-dependent avidity thresholds for cytotoxic T-lymphocyte clearance of virus-infected cells. J Virol 2007, 81:4973-4980. 10.1128/JVI.02362-06, 1900201, 17329324.
25. Almeida JR, Sauce D, Price DA, Papagno L, Shin SY, Moris A, Larsen M, Pancino G, Douek DC, Autran B, et al. Antigen sensitivity is a major determinant of CD8+ T cell polyfunctionality and HIV-suppressive activity. Blood 2009, 113:6351-6360. 10.1182/blood-2009-02-206557, 2710928, 19389882.
26. Allen TM, Yu XG, Kalife ET, Reyor LL, Lichterfeld M, John M, Cheng MF, Allgaier RL, Mui S, Frahm N, et al. De novo generation of escape variant-specific CD8+ T-cell responses following cytotoxic T-lymphocyte escape in chronic human immunodeficiency virus type 1 infection. J Virol 2005, 79:12952-12960. 10.1128/JVI.79.20.12952-12960.2005, 1235830, 16188997.
27. Feeney ME, Tang Y, Pfafferott K, Roosevelt KA, Draenert R, Trocha A, Yu XG, Verrill CL, Allen T, Moore C, et al. HIV-1 viral escape in infancy followed by emergence of a variant-specific CTL response. J Immunol 2005, 174:7524-7530.
28. Lichterfeld M, Yu XG, Cohen D, Addo MM, Malenfant J, Perkins B, Pae E, Johnston MN, Strick D, Allen TM, et al. HIV-1 Nef is preferentially recognized by CD8 T cells in primary HIV-1 infection despite a relatively high degree of genetic diversity. AIDS 2004, 18:1383-1392. 10.1097/01.aids.0000131329.51633.a3, 15199314.
29. O'Connor DH, Allen TM, Vogel TU, Jing P, DeSouza IP, Dodds E, Dunphy EJ, Melsaether C, Mothe B, Yamamoto H, et al. Acute phase cytotoxic T lymphocyte escape is a hallmark of simian immunodeficiency virus infection. Nature Med 2002, 8:493-499. 10.1038/nm0502-493, 11984594.
30. Valentine LE, Piaskowski SM, Rakasz EG, Henry NL, Wilson NA, Watkins DI. Recognition of escape variants in ELISPOT does not always predict CD8+ T-cell recognition of simian immunodeficiency virus-infected cells expressing the same variant sequences. J Virol 2008, 82:575-581. 10.1128/JVI.00275-07, 2224389, 17959674.
31. Goulder PJ, Watkins DI. Impact of MHC class I diversity on immune control of immunodeficiency virus replication. Nat Rev Immunol 2008, 8:619-630. 10.1038/nri2357, 2963026, 18617886.
32. Zajac AJ, Blattman JN, Murali Krishna K, Sourdive DJD, Suresh M, Altman JD, Ahmed R. Viral immune evasion due to persistence of activated T cells without effector function. J Exp Med 1998, 188:2205-2213. 10.1084/jem.188.12.2205, 2212420, 9858507.
33. Wherry EJ, Blattman JN, Murali-Krishna K, van der Most R, Ahmed R. Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment. J Virol 2003, 77:4911-4927. 10.1128/JVI.77.8.4911-4927.2003, 152117, 12663797.
34. Mueller SN, Ahmed R. High antigen levels are the cause of T cell exhaustion during chronic viral infection. Proc Natl Acad Sci USA 2009, 106:8623-8628. 10.1073/pnas.0809818106, 2688997, 19433785.
35. Lichterfeld M, Kavanagh DG, Williams KL, Moza B, Mui SK, Miura T, Sivamurthy R, Allgaier R, Pereyra F, Trocha A, et al. A viral CTL escape mutation leading to immunoglobulin-like transcript 4-mediated functional inhibition of myelomonocytic cells. J Exp Med 2007, 204:2813-2824. 10.1084/jem.20061865, 2118510, 18025130.
36. Day EK, Carmichael AJ, ten Berge IJ, Waller EC, Sissons JG, Wills MR. Rapid CD8+ T cell repertoire focusing and selection of high-affinity clones into memory following primary infection with a persistent human virus: human cytomegalovirus. J Immunol 2007, 179:3203-3213.
37. Slifka MK, Whitton JL. Functional avidity maturation of CD8(+) T cells without selection of higher affinity TCR. Nat Immunol 2001, 2:711-717.
38. Dong T, Stewart-Jones G, Chen N, Easterbrook P, Xu X, Papagno L, Appay V, Weekes M, Conlon C, Spina C, et al. HIV-specific cytotoxic T cells from long-term survivors select a unique T cell receptor. J Exp Med 2004, 200:1547-1557. 10.1084/jem.20032044, 2212004, 15596521.
39. Turnbull EL, Lopes AR, Jones NA, Cornforth D, Newton P, Aldam D, Pellegrino P, Turner J, Williams I, Wilson CM, et al. HIV-1 epitope-specific CD8+ T cell responses strongly associated with delayed disease progression cross-recognise epitope variants efficiently. J Immunol 2006, 176:6130-6146.
40. Fellay J, Shianna KV, Ge D, Colombo S, Ledergerber B, Weale M, Zhang K, Gumbs C, Castagna A, Cossarizza A, et al. A whole-genome association study of the major determinants for host control of HIV-1. Science 2007, 317:944-947. 10.1126/science.1143767, 1991296, 17641165.
41. Salazar-Gonzalez JF, Bailes E, Pham KT, Salazar MG, Guffey MB, Keele BF, Derdeyn CA, Farmer P, Hunter E, Allen S, et al. Deciphering human immunodeficiency virus type 1 transmission and early envelope diversification by single-genome amplification and sequencing. J Virol 2008, 82:3952-3970. 10.1128/JVI.02660-07, 2293010, 18256145.